Company intelligence / Profile preview

Zhaoke Ophthalmology

Ownership: Private
Employees: ~294
Development stage: Other

Overview

The company has a comprehensive drug portfolio covering six major eye diseases across both the front and back of the eye. They have recently entered distribution agreements for various markets.

Therapeutic areas: Ophthalmology
Modalities: Small molecules
Industry: Biotech

Drug pipeline

8 assets

germinal peptide

7 more assets in the full pipeline.

Partnerships

AFT Pharmaceuticals (Australia and New Zealand)Kwangdong Pharmaceutical (South Korea)Lunatus (Middle East)InterPharma (Thailand)

Beyond the preview

Go deeper on Zhaoke Ophthalmology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhaoke Ophthalmology.